Company: MDCXW
Filing Date: 2025-05-05
Form Type: 424B3
Source: 0001062993-25-008444
Chunk: 50

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-05
Form: 424B3
Chunk 50
---
. Ciaruffoli     |                              |                |
| /s/ Frank Lavelle        | Director                     | April 30, 2025 |
| Frank Lavelle            |                              |                |
| /s/ William L. Ashton    | Director                     | April 30, 2025 |
| William L. Ashton        |                              |                |
| /s/ Barry Fishman        | Director                     | April 30, 2025 |
| Barry Fishman            |                              |                |
| /s/ Sara R. May          | Director                     | April 30, 2025 |
| Dr. Sara R. May          |                              |                |

<div align='center'>36

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): y 2,

MEDICUS PHARMA LTD.(Exact name of registrant as specified in its charter)</div>

| Ontario                      | 001-42408   | 98-1778211         |
| (State or other jurisdiction 
 of incorporation)            | -Commission 
 File Number | -IRS Employer      
 Identification No. |

<div align='center'>300 Conshohocken State Road, Suite 200United States 19428
(Address of principal executive offices) (ZIP Code)

Registrant's telephone number, including area code: ()</div>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

| Title of each class                           |     | Trading Symbols |     | Name of each exchange on which 
 registered                     |
| Common shares